Empagliflozin
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Empagliflozin |
| DrugBank ID | DB09038 |
| KG Predictions | 30 |
| DL Predictions (≥0.7) | 0 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 30 knowledge graph predictions and 0 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| type 2 diabetes mellitus | KG |
| diabetes mellitus (disease) | KG |
| type 2 diabetes mellitus | KG |
| diabetes mellitus (disease) | KG |
| type 2 diabetes mellitus | KG |
| diabetes mellitus (disease) | KG |
| type 2 diabetes mellitus | KG |
| diabetes mellitus (disease) | KG |
| type 2 diabetes mellitus | KG |
| diabetes mellitus (disease) | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB09038
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.